Cargando…
Management of Refractory Orofacial Dyskinesia Caused by Anti-N-methyl-d-aspartate Receptor Encephalitis Using Botulinum Toxin
The use of botulinum neurotoxin serotype A (BoNT-A) injections for the treatment of orofacial dyskinesia secondary to anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is rarely reported. Here, we report a case of an urgent, successful management of severe orofacial dyskinesia in an 8-year-old...
Autores principales: | Zheng, Feixia, Ye, Xiuyun, Shi, Xulai, Poonit, Neha Devi, Lin, Zhongdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827093/ https://www.ncbi.nlm.nih.gov/pubmed/29520252 http://dx.doi.org/10.3389/fneur.2018.00081 |
Ejemplares similares
-
Association between clinical factors and orofacial dyskinesias in anti‐N‐methyl‐D‐aspartate receptor encephalitis
por: Hang, Hailun, et al.
Publicado: (2022) -
Unusual brain images of a boy with adolescent cerebral X-linked adrenoleukodystrophy presenting with exhibitionism: A CARE-compliant case report
por: Zheng, Feixia, et al.
Publicado: (2017) -
Prevention of oral and maxillofacial trauma secondary to orofacial dyskinesias associated with anti-N-methyl-d-aspartate receptor encephalitis: a case series
por: Chadwick, Jeffrey W., et al.
Publicado: (2021) -
Use of Botulinum Toxin in Orofacial Clinical Practice
por: Serrera-Figallo, Maria-Angeles, et al.
Publicado: (2020) -
Hyponatremia in Children With Bacterial Meningitis
por: Zheng, Feixia, et al.
Publicado: (2019)